AMSBIO introduced a new range of neural progenitor cells, and cerebral cortical neurons, derived from human induced pluripotent stem (iPS) cells. The company can provide healthy and Alzheimer disease patient derived cerebral cortical neurons and neural progenitor cells. This accessible, in vitro human-based system offers a platform to build human cellular models to study conditions including Alzheimer’s, autism, epilepsy, traumatic brain injury and stroke. Derived using integration-free fully defined neural induction conditions, these cells are electrically active, form functional synapses in vitro and can be transplanted into animal models. Available in industrial quantities, the cerebral cortical neurons and neural progenitor cells are supplied with extensive functional and molecular characterization data.  All products are supplied ready-made and remain viable in culture for months to facilitate reproducible and long term studies. Cells from multiple donors are available for purchase allowing data comparison among biological replicates.

AMSBIO, +44-1235-828200, http://www.amsbio.com/Human-Neural-Stem-Cells.aspx